Ngā hua rapu - Anagnostou, Valsamo

Primary parotid adenocarcinoma metastasis to the spleen with PIK3CA mutation: cytological findings and review of the literature mā Inouye, Casey M, Anagnostou, Valsamo, Li, Qing Kay

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas mā Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Developing a Multivariable Prognostic Model for Pancreatic Endocrine Tumors Using the Clinical Data Warehouse Resources of a Single Institution mā Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Can... mā Dimou, Anastasios, Agarwal, Seema, Anagnostou, Valsamo, Viray, Hollis, Christensen, Stephen, Gould Rothberg, Bonnie, Zolota, Vassiliki, Syrigos, Konstantinos, Rimm, David L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Antibody validation mā Bordeaux, Jennifer, Welsh, Allison W., Agarwal, Seema, Killiam, Elizabeth, Baquero, Maria T., Hanna, Jason A., Anagnostou, Valsamo K., Rimm, David L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity mā Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M., Forde, Patrick M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Analytic Variability in Immunohistochemistry Biomarker Studies mā Anagnostou, Valsamo K., Welsh, Allison W., Giltnane, Jennifer M., Siddiqui, Summar, Liceaga, Camil, Gustavson, Mark, Syrigos, Konstantinos N., Reiter, Jill L., Rimm, David L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells mā Zito, Christopher R., Jilaveanu, Lucia B., Anagnostou, Valsamo, Rimm, David, Bepler, Gerold, Maira, Sauveur-Michel, Hackl, Wolfgang, Camp, Robert, Kluger, Harriet M., Chao, Herta H.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues mā Neumeister, Veronique M., Anagnostou, Valsamo, Siddiqui, Summar, England, Allison Michal, Zarrella, Elizabeth R., Vassilakopoulou, Maria, Parisi, Fabio, Kluger, Yuval, Hicks, David G., Rimm, David L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro mā Cross, Sarah N., Cocco, Emiliano, Bellone, Stefania, Anagnostou, Valsamo K., Brower, Stacey L., Richter, Christine E., Siegel, Eric R., Schwartz, Peter E., Rutherford, Thomas J., Santin, Alessandro D.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Programmed death ligand-1 expression in non-small cell lung cancer mā Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Rimm, David L, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Syrigos, Konstantinos N

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Artificial intelligence-assisted serial analysis of clinical cancer genomics data identifies changing treatment recommendations and therapeutic targets mā Fischer, Catherine G., Pallavajjala, Aparna, Jiang, LiQun, Anagnostou, Valsamo, Tao, Jessica, Adams, Emily, Eshleman, James R., Gocke, Christopher D., Lin, Ming-Tseh, Platz, Elizabeth A., Xian, Rena R.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: a Randomized Phase II Study mā Osborne, C. Kent, Neven, Patrick, Dirix, Luc Y., Mackey, John R., Robert, Jean, Underhill, Craig, Schiff, Rachel, Gutierrez, Carolina, Migliaccio, Ilenia, Anagnostou, Valsamo K., Rimm, David L., Magill, Patrick, Sellers, Mark

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue mā Neumeister, Veronique M., Parisi, Fabio, England, Allison M., Siddiqui, Summar, Anagnostou, Valsamo, Zarrella, Elizabeth, Vassilakopolou, Maria, Bai, Yalai, Saylor, Sasha, Sapino, Anna, Kluger, Yuval, Hicks, David G., Bussolati, Gianni, Kwei, Stephanie, Rimm, David L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

High-throughput prediction of MHC class I and class II neoantigens with MHCnuggets mā Shao, Xiaoshan M., Bhattacharya, Rohit, Huang, Justin, Sivakumar, I.K. Ashok, Tokheim, Collin, Zheng, Lily, Hirsch, Dylan, Kaminow, Benjamin, Omdahl, Ashton, Bonsack, Maria, Riemer, Angelika B., Velculescu, Victor E., Anagnostou, Valsamo, Pagel, Kymberleigh A., Karchin, Rachel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology mā Anagnostou, Valsamo K, Lowery, Frank J, Zolota, Vassiliki, Tzelepi, Vassiliki, Gopinath, Arun, Liceaga, Camil, Panagopoulos, Nikolaos, Frangia, Konstantina, Tanoue, Lynn, Boffa, Daniel, Gettinger, Scott, Detterbeck, Frank, Homer, Robert J, Dougenis, Dimitrios, Rimm, David L, Syrigos, Konstantinos N

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Personalized genomic analyses for cancer mutation discovery and interpretation mā Jones, Siân, Anagnostou, Valsamo, Lytle, Karli, Parpart-Li, Sonya, Nesselbush, Monica, Riley, David R., Shukla, Manish, Chesnick, Bryan, Kadan, Maura, Papp, Eniko, Galens, Kevin G., Murphy, Derek, Zhang, Theresa, Kann, Lisa, Sausen, Mark, Angiuoli, Samuel V., Diaz, Luis A., Velculescu, Victor E.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer mā Scott, Kenneth L., Kabbarah, Omar, Liang, Mei-Chih, Ivanova, Elena, Anagnostou, Valsamo, Wu, Joyce, Dhakal, Sabin, Wu, Min, Chen, Shujuan, Feinberg, Tamar, Huang, Joseph, Saci, Abdel, Widlund, Hans R., Fisher, David E., Xiao, Yonghong, Rimm, David L., Protopopov, Alexei, Wong, Kwok-Kin, Chin, Lynda

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A machine learning approach for somatic mutation discovery mā Wood, Derrick E., White, James R., Georgiadis, Andrew, Van Emburgh, Beth, Parpart-Li, Sonya, Mitchell, Jason, Anagnostou, Valsamo, Niknafs, Noushin, Karchin, Rachel, Papp, Eniko, McCord, Christine, LoVerso, Peter, Riley, David, Diaz, Luis A., Jones, Siân, Sausen, Mark, Velculescu, Victor E., Angiuoli, Samuel V.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial mā Kok, Peey Sei, Forde, Patrick M, Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O’Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M, Stockler, Martin, Nowak, Anna K

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa